Live-style venture timeline
Follow the newest VC fund closes and funding rounds with date-first updates. Every entry links to a blog article with context and source coverage.
Subscribe via RSSOneByZero raises $20M Series A
Singapore-headquartered OneByZero raised its first external capital, a $20 million Series A led by Jungle Ventures, to expand enterprise AI deployments across Asia and the Middle East.
RobCo exceeds $1B valuation in reported $40M employee-liquidity transaction
RobCo confirmed employee liquidity and new investment at a valuation above $1 billion. The Wall Street Journal reported a $40 million transaction, most of it secondary shares sold by employees.
Supabase announces $150M financing led by GIC
$150M disclosed round led by GIC with CapitalG, IronArc and SquarePeg. New valuation and capital-versus-employee-liquidity split undisclosed.
Supabase announces acquisition of Turso
Acquisition announced 2 October 2026. Purchase price and definitive legal closing date not disclosed. The separate $150M Supabase financing is not the acquisition consideration.
Fairtide commits $800M to purchase Maxwell Power projects
Fairtide Partners closed an $800 million commitment to purchase battery-storage and solar projects developed by Maxwell Power. This is project-acquisition capital, not conventional venture equity.
TriGemX Bio closes $94M financing
TriGemX Bio, formerly Kallyope, closed $94 million to fund Phase 3 trials of the investigational migraine drug elismetrep.
Homeward closes $120M Series D and $330M asset-backed debt facilities
Homeward raised $120 million of Series D equity led by Saluda Grade and arranged $330 million of asset-backed debt facilities to fund home transactions. The debt is not venture equity.
doxx.net raises $38M Series A
doxx.net raised a $38 million Series A led by Andreessen Horowitz as it launched the open beta of its Agentic Defined Networking platform.
Volantis raises $88M Series A
Volantis raised an $88 million Series A to develop and commercialize its photonic A-1 AI inference system, with first integrated customer deliveries targeted for 2027.
LAUNCHub Ventures reaches €65M first close for Fund III
LAUNCHub Ventures secured €65 million at the first close of Fund III, targeting more than €75 million for about 25 pre-seed and seed investments across CEE, SEE and the region's diaspora.
DIG Ventures closes $120M Fund III
DIG Ventures closed its third fund at $120 million to back roughly 30 pre-seed and seed enterprise AI, cloud and software-infrastructure startups across Europe and Israel.
Headline EU VIII $400M final close
Headline closed EU VIII at $400 million to back European seed and Series A companies, with a focus on AI.
PaleBlueDot AI $200M Series C
PaleBlueDot AI completed a $200 million Series C led by ComputeCore at a $3.2 billion valuation.
GMI Cloud $223M Series B and $445M credit facility
GMI Cloud combined a $223 million Series B with a separate $445 million credit facility.
Armadin $255.5M Series B
Armadin raised $255.5 million in a Series B co-led by a16z and Accel at a valuation above $2.5 billion.
Fortem Technologies closes $50M Series B led by Lockheed Martin
Counter-UAS company Fortem Technologies closed a $50M Series B led by Lockheed Martin to scale its integrated radar, command-and-control and autonomous interceptor platform.
Flow Engineering raises $50M Series B at $750M valuation
Flow Engineering announced a $50M Series B at a $750M valuation for its AI systems-engineering agents used in complex hardware development.
CScale raises $145M Series C
CScale raised $145 million to commercialize a fault-tolerant optical interconnect for scale-up AI infrastructure, bringing total funding to $188 million.
Varda Space Industries $251M Series D
Varda raised $251 million in a Series D co-led by Lux Capital and Natural Capital; a $1.6 billion valuation was reported by media.
R1 Therapeutics adds $3M to Series A
Samsara BioCapital invested $3 million to expand R1 Therapeutics' Series A from $77.5 million to $80.5 million ahead of expected Phase 2b data in H1 2027.
BAG Ventures closes $11.3M Fund I
BAG Ventures closed its inaugural $11.3 million fund to back pre-seed and seed enterprise AI companies, using more than 150 operator LPs as a customer-access and go-to-market network.
Metaview $60M Series C
Metaview raised $60 million in a Series C led by Insight Partners, taking disclosed funding to $110 million as it expands from interview intelligence into agentic recruiting workflows.
ElevenLabs $300M employee tender at $22B valuation
Employees and existing investors sold $300 million of shares in a secondary tender that valued ElevenLabs at $22 billion. The company did not receive the tender proceeds.
ArkeaBio raises $15M Series A2
Series A2 led by AgriZeroNZ to finance New Zealand regulatory work and a planned 2028 commercial launch.
Audax Direct Lending Solutions Fund III final close
Final close with $5.4B of commitments and $10B of investable capacity including leverage, related vehicles and GP capital.
Simple Energy closes ₹1,750 crore Series C
All-equity Series C led by the Arokiaswamy Velumani Family Office to expand manufacturing, production, retail and service.
Friends & Family Capital IV reaches $300M first close
$300M first close for Fund IV. A further $50M–$100M of verbal LP interest is not counted as closed capital.
Relay raises $36M for frontline operations platform
Customer International Paper led Relay's $36M financing; the company disclosed no stage or valuation.
OpenAI reported $30B private-round talks at $1.4T pre-money
Early-stage talks for at least $30B at about $1.4T pre-money. No financing has closed.
Clio acquires Learned Hand
Clio acquired judiciary-AI startup Learned Hand for undisclosed consideration.
EDT raises $2.4M pre-Series A
EDT raised $2.4M in an oversubscribed pre-Series A led by Sauce VC, with Alteria Capital and operator-angels participating.
Arivihan raises $10M Series A
Economic Times reported a $10M Series A co-led by Accel and Prosus Ventures; filings cited by ET imply a roughly ₹570 crore valuation.
AnaCardio closes €62.5M Series B
AnaCardio completed a €62.5 million Series B that is intended to fully fund the approximately 400-patient GOAL-HF2 Phase 2b trial of oral heart-failure drug AC01.
Rising Point Capital closes $325M Fund I
Rising Point Capital closed its inaugural institutional private equity fund at $325 million, above a $250 million target, to back founder- and family-led lower-middle-market field-services companies.
NorthStar Medical secures up to $185M growth capital facility
NorthStar Medical Technologies secured a multi-year growth-capital facility of up to $185 million from Hercules Capital, including $100 million funded upfront, to expand actinium-225 production and radiopharmaceutical manufacturing.
General Intuition raises $220M at $6.2B
Confirmed $220 million financing at a $6.2 billion valuation; formal stage was not disclosed.
Breye Therapeutics raises €67.5M Series A
Breye Therapeutics announced an oversubscribed €67.5M Series A co-led by Mission BioCapital and Novo Holdings.
